The probability of developing ocular EIMs was comparable across treatment classes among patients with HLA-B27-associated diseases.

Ustekinumab and vedolizumab have comparable safety and efficacy in older and younger adults with IBD, indicating that age should not be a deterrent for treatment.

Tetrachloroethylene (PCE) exposure was linked to a tripled risk for significant liver fibrosis, with a dose-dependent effect.

Moderate-to-vigorous physical activity guideline adherence was associated with a 22% and 17% lower CHD risk in women and men, respectively.

There was a significant association between early age of natural menopause vs late age and metabolic syndrome.

Type 2 diabetes prevalence among children aged 5 years or less is associated with social and environmental factors.

Individuals with MetALD vs MASLD have significantly higher risks for liver-related events, liver cancer, and extrahepatic cancers.

The presence of metabolic dysfunction-associated steatotic liver disease may be a predictor of disease trajectory in patients with MACE.

Sugar rationing during the first 1000 days of life was associated with a reduction in the risk for cardiovascular outcomes in adulthood.

MACE risk was associated with waist circumference reduction but not weight loss among those receiving semaglutide.

The global prevalence of self-reported non-celiac gluten or wheat sensitivity was 10.3%, with some variation seen between countries.

Behavioral interventions, such as text messages and mailed reminders, significantly improve fecal immunochemical test completion among adults overdue for screening.